Donanemab Confirms: Clearing Plaques Slows Decline—By a Bit | ALZFORUM – Alzforum

19 Mar 2021
It has been clear for a while that anti-amyloid antibodies can sweep plaque from the brain, but until now the question of whether this slows cognitive decline has remained hotly contended. Despite some positive signals from four such antibodies, the data have been messy and hard to interpret. At the 15th International Conference on Alzheimers and Parkinsons Diseases, held virtually March 1014, Mark Mintun of Eli Lilly & Company presented the cleanest data yet on this question. In a Phase…

Click here to view the original article.